<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
 <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
 <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
 <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus Broad dengue neutralization in mosquitoes expressing an engineered"/>
 <result pre="an engineered single-chain variable fragment derived from a broadly neutralizing" exact="DENV" post="human monoclonal antibody and have significantly reduced viral infection,"/>
 <result pre="dissemination, and transmission rates for all four major antigenically distinct" exact="DENV" post="serotypes. Importantly, this is the first engineered approach that"/>
 <result pre="Importantly, this is the first engineered approach that targets all" exact="DENV" post="serotypes, which is crucial for effective disease suppression. These"/>
 <result pre="These results provide a compelling route for developing effective genetic-based" exact="DENV" post="control strategies, which could be extended to curtail other"/>
 <result pre="the transgene throughout wild disease-transmitting mosquito populations and preventing further" exact="DENV" post="transmission. Since a number of diverse and well-characterized antibodies"/>
 <result pre="are within the manuscript and its Supporting Information files Introduction" exact="Dengue" post="fever is a devastating viral disease caused by several"/>
 <result pre="readily controlled using broad-spectrum techniques [1,2]. Transmitted by infected mosquitoes," exact="DENV" post="infection typically manifests as severe fever, headaches, and myalgia[3]"/>
 <result pre="dengue hemorrhagic fever and dengue shock syndrome[4]. Global incidences of" exact="DENV" post="and its associated economic burden have increased dramatically in"/>
 <result pre="the disease-spreading mosquitoes is currently the best option for preventing" exact="DENV" post="transmission [13]. Aedes aegypti [16], the main vector of"/>
 <result pre="DENV transmission [13]. Aedes aegypti [16], the main vector of" exact="DENV" post="and other epidemiologically significant viruses such as chikungunya (CHIKV),"/>
 <result pre="significant viruses such as chikungunya (CHIKV), yellow fever (YFV), and" exact="Zika" post="(ZIKV), is a domestic endophilic mosquito[17] that has expanded"/>
 <result pre="manner and can inhibit mosquito infection with pathogens such as" exact="DENV" post="and ZIKV[28,29], have also been carried out. These have"/>
 <result pre="genes, and several approaches for engineering Ae. aegypti resistance to" exact="DENV" post="have been attempted. For example, one study used RNA"/>
 <result pre="their ability to target only one or two—not all four—major" exact="DENV" post="serotypes. Because hyperendemicity of DENV in tropical areas is"/>
 <result pre="one or two—not all four—major DENV serotypes. Because hyperendemicity of" exact="DENV" post="in tropical areas is frequent[5] and secondary DENV infection"/>
 <result pre="hyperendemicity of DENV in tropical areas is frequent[5] and secondary" exact="DENV" post="infection has been linked to severe dengue disease (SDD),"/>
 <result pre="studies demonstrated that this antibody neutralized viruses from all major" exact="DENV" post="serotypes and was capable of significantly reducing viremia in"/>
 <result pre="variable fragment (scFv) that is capable of neutralizing all four" exact="DENV" post="serotypes[44]. Crucially, we demonstrate that mosquitoes expressing this anti-DENV"/>
 <result pre="cannot be infected with or transmit any of the four" exact="DENV" post="serotypes and have few significant fitness costs conferred by"/>
 <result pre="antibody. These results provide a promising route for developing effective" exact="DENV" post="control strategies using genetically engineered mosquitoes. Materials and methods"/>
 <result pre="the chemiluminescent HRP substrate (Millipore, Cat. No#WBKLS0500) to the blots." exact="DENV" post="infection of mosquitoes and virus determination All experiments were"/>
 <result pre="the insectary at the Australian Animal Health Laboratory. The following" exact="DENV" post="strains were used for all viral challenge experiments: DENV-1"/>
 <result pre="by red fluorescence in the eye) mosquitoes were exposed to" exact="DENV" post="as described previously [61]. Briefly, female mosquitoes were challenged"/>
 <result pre="infection and dissemination were carried out as previously described [61]." exact="DENV" post="infection frequency was defined by the number of midguts"/>
 <result pre="the WT line, and the resulting offspring were used for" exact="DENV" post="infection experiments. At the end of the experiment, the"/>
 <result pre="as our model due to its ability to cross-neutralize multiple" exact="DENV" post="serotypes in humans[44]. As it is a human monoclonal"/>
 <result pre="Effect of anti-dengue virus (DENV) single-chain variable fragment (scFv) on" exact="DENV" post="titers of TADV-A, Wolbachia-infected (wMel), and wildtype (WT) mosquitoes."/>
 <result pre="challenged with a blood meal infected with one of four" exact="DENV" post="serotypes (DENV-1, isolate ET243; DENV-2, isolate ET300; DENV-3, isolate"/>
 <result pre="determine if the anti-DENV transgene confers resistance to all four" exact="DENV" post="serotypes, we determined viral titers in extracted midguts, carcasses,"/>
 <result pre="context (i.e., in the midgut following a blood meal) for" exact="DENV" post="suppression. Engineered mosquitoes are resistant to infection with all"/>
 <result pre="suppression. Engineered mosquitoes are resistant to infection with all four" exact="DENV" post="serotypes To determine the functional significance of anti-DENV 1C19"/>
 <result pre="post infection (dpi), midguts from blood-fed mosquitoes were dissected, and" exact="DENV" post="RNA copies were measured using RT-qPCR. All three lines"/>
 <result pre="comprehensive characterization. For a more detailed study of the TADV-A" exact="DENV" post="vector competence, the effect of transgene zygosity on the"/>
 <result pre="(Fig 1B, Table 1). 10.1371/journal.ppat.1008103.t001Table 1 Anti-DENV scFv effect on" exact="DENV" post="infection, dissemination, and transmission rates. DENV titers in WT,"/>
 <result pre="Anti-DENV scFv effect on DENV infection, dissemination, and transmission rates." exact="DENV" post="titers in WT, heterozygous and homozygous TADV-A (TADV-AHt and"/>
 <result pre="mosquitoes following a blood meal infected with one of four" exact="DENV" post="serotypes are shown. DENV GE from mosquito midguts (at"/>
 <result pre="meal infected with one of four DENV serotypes are shown." exact="DENV" post="GE from mosquito midguts (at 4 or 14 dpi)"/>
 <result pre="at 14 dpi were determined using TCID50 on Vero cells." exact="DENV" post="GE or viral titer on indicated dpi from specified"/>
 <result pre="mosquitoes with detected virus; percentage of mosquitoes with detected virus)" exact="DENV" post="Serotype Strain 4 dpi 14 dpi Midgut–GE Midgut–GE Carcass–GE"/>
 <result pre="whether the anti-DENV 1C19 scFv is broadly inhibitory for other" exact="DENV" post="serotypes, the vector competence of TADV-A mosquitoes was assessed"/>
 <result pre="positive for the virus in most specimens, though the overall" exact="DENV" post="titers were significantly lower than compared to the WT"/>
 <result pre="compare the inhibitory effect of the anti-DENV 1C19 scFv to" exact="DENV" post="inhibition through Wolbachia[65–67] infection, we challenged WT mosquitoes infected"/>
 <result pre="reduced (p &amp;lt; 0.001) in wMel mosquitoes (~3 log10), and" exact="DENV" post="titers in mosquito saliva at 14 dpi were significantly"/>
 <result pre="effective as homozygotes, and similarly effective as heterozygotes, at blocking" exact="DENV" post="infection as Wolbachia-infected mosquitoes. Transgene impact on fitness To"/>
 <result pre="assessed. Transgenic, WT, or wMel mosquitoes were infected with four" exact="DENV" post="serotypes and their survivorship was assessed 14 dpi (Table"/>
 <result pre="and the percent of surviving mosquitoes separately infected by four" exact="DENV" post="serotypes was assessed at 14 dpi. Strain Fitness Parameter"/>
 <result pre="anti-DENV 1C19 scFv renders mosquitoes refractory to all four major" exact="DENV" post="serotypes and therefore appears to be a potent viral"/>
 <result pre="homozygous for the anti-DENV 1C19 scFv showed complete refractoriness to" exact="DENV" post="infection, heterozygous mosquitoes were still partially refractory to DENV"/>
 <result pre="to DENV infection, heterozygous mosquitoes were still partially refractory to" exact="DENV" post="infection, dissemination, and transmission, with significant, several orders-of-magnitude reductions"/>
 <result pre="mosquitoes [63], it binds to the exposed fusion loop of" exact="DENV" post="and inhibits the virus particle from releasing its genome"/>
 <result pre="would be sufficient to render heterozygous mosquitoes unable to transmit" exact="DENV" post="to a susceptible host[68]. Though this remains to be"/>
 <result pre="more efficient than—Wolbachia-infected mosquitoes, which are currently being released for" exact="DENV" post="control because they are known to be refractory to"/>
 <result pre="a gene-drive system to reduce or eliminate the risk of" exact="DENV" post="transmission by mosquitoes. In fact, previous efforts have demonstrated"/>
 <result pre="populations into transgenic homozygotes that would be completely resistant to" exact="DENV" post="transmission. Of paramount importance to the viability of such"/>
 <result pre="evolution. Indeed, several studies have shown that, in some contexts," exact="DENV" post="can rapidly evolve resistance in response to neutralizing antibodies"/>
 <result pre="as well as a combination of antibody and non-antibody based" exact="DENV" post="refractoriness transgenes (e.g., [36,37]; [38]; [39])). The deployment of"/>
 <result pre="far-reaching consequences for rendering mosquitoes resistant to other arboviruses like" exact="ZIKV" post="and CHIKV by using similar genetic engineering strategies to"/>
 <result pre="for rendering mosquitoes resistant to other arboviruses like ZIKV and" exact="CHIKV" post="by using similar genetic engineering strategies to develop scFv-based"/>
 <result pre="data file. S3 Fig Effect of the anti-DENV scFv on" exact="DENV" post="GE in three independent transgenic mosquito lines. DENV GE"/>
 <result pre="scFv on DENV GE in three independent transgenic mosquito lines." exact="DENV" post="GE in WT and transgenic mosquito lines (TADV-A, TADV-B,"/>
 <result pre="a blood meal infected with DENV-2 (ET300 strain) are shown." exact="DENV" post="GE from mosquito midguts (at 4 dpi) of WT"/>
 <result pre="dengue control. Armed Forces Med J India. 2015;71: 67–70. 3WhitehornJ." exact="Dengue" post="Fever Viruses. eLS. John Wiley &amp;amp; Sons, Ltd; 2001."/>
 <result pre="Fever Viruses. eLS. John Wiley &amp;amp; Sons, Ltd; 2001. 4RajapakseS." exact="Dengue" post="shock. J Emerg Trauma Shock. 2011;4: 120–127. 10.4103/0974-2700.7683521633580 5MessinaJP,"/>
 <result pre="DesedaC, ChotpitayasunondhT, DietzeR, et al.Efficacy and Long-Term Safety of a" exact="Dengue" post="Vaccine in Regions of Endemic Disease. N Engl J"/>
 <result pre="PLoS Negl Trop Dis. 2017;11: e000563210.1371/journal.pntd.000563228749942 21HaugCJ, KienyMP, MurgueB. The" exact="Zika" post="Challenge. N Engl J Med. 2016;374: 1801–1803. 10.1056/NEJMp160373427028782 22GattonML,"/>
 <result pre="VelezID, OsorioJE. The wMel strain of Wolbachia Reduces Transmission of" exact="Zika" post="virus by Aedes aegypti. Sci Rep. 2016;6: 2879210.1038/srep2879227364935 29WalkerT,"/>
 <result pre="DasS, PotiKE, et al.Engineered Aedes aegypti JAK/STAT Pathway-Mediated Immunity to" exact="Dengue" post="Virus. PLoS Negl Trop Dis. 2017;11: e000518710.1371/journal.pntd.000518728081143 40BurtonDR, PoignardP,"/>
 <result pre="Proteins. CSH Protoc. 2006;200610.1101/pdb.prot431322485689 61DucheminJ-B, MeePT, LynchSE, VedururuR, TrinidadL, ParadkarP." exact="Zika" post="vector transmission risk in temperate Australia: a vector competence"/>
 <result pre="Transmission of Aedes aegypti Transmitted Viruses In: HilgenfeldR, VasudevanSG, editors." exact="Dengue" post="and Zika: Control and Antiviral Treatment Strategies. Singapore: Springer"/>
 <result pre="et al.Structural basis of a potent human monoclonal antibody against" exact="Zika" post="virus targeting a quaternary epitope. Proc Natl Acad Sci"/>
 <result pre="Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against" exact="Chikungunya" post="Virus. Cell Host Microbe. 2015;18: 382. 81GooL, DebbinkK, KoseN,"/>
 <result pre="DoyleMP, WesselAW, et al.A protective human monoclonal antibody targeting the" exact="West Nile" post="virus E protein preferentially recognizes mature virions. Nat Microbiol."/>
</results>
